Aid by Sector
South Sudan Health Pooled Fund Phase III
UK - Foreign, Commonwealth Development Office (FCDO)
To provide a government led effective health system that will deliver improved access to quality health services across seven states in South Sudan with a specific focus on reducing maternal and child mortality. The Health Pooled Fund (HPF3) will reduce maternal and under-five mortality rates in South Sudan, through (i) the delivery of a basic package of health and nutrition services; (ii) promoting community engagement in health as a public good and (iii) supporting local health systems stabilisation.
LAFIYA -UK Support for Health in Nigeria
UK - Foreign, Commonwealth Development Office (FCDO)
To save lives, reduce suffering and improve economic prospects for the poorest and most vulnerable in Nigeria through: i. Encouraging Government of Nigeria to increase resources invested in health (through advocacy, community accountability; and data to inform government prioritisation using a “delivery” approach, as used successfully in Pakistan) ii. Improving effectiveness and efficiency of public and private basic health services (through innovative financing mechanisms, strengthening health systems and working with private sector to deliver affordable health services for the poorest populations) iii. Reducing total fertility rate (through addressing social norms, demographic impact analysis, and support to family planning commodities and services).
Umoyo Wathu Health System Strengthening Programme
UK - Foreign, Commonwealth Development Office (FCDO)
To reduce rates and inequalities in maternal, under-5 and new-born deaths; as well as reduce stunting in under-5s, by strengthening the quality and coverage of a package of essential health services through lower level district administration. The programme will increase the provision and uptake of quality, highly cost effective life-saving primary healthcare services provided free at the point of use, and so better protect the most vulnerable against the financial consequences of ill health. By 2028, the programme will contribute to reducing maternal mortality from 439 to 350 per 100,000 births; neonatal mortality from 27 to 22 per 1,000 live births; child mortality from 64 to 48 per 1,000 live births; stunting in children under five years of age reduced from 37% to 31%; and impact of communicable disease outbreaks and epidemics.
Strengthening the Health System and Provision of Essential Services in South Sudan (SHAPES)
UK - Foreign, Commonwealth Development Office (FCDO)
To provide a government led effective health system that will deliver improved access to quality health services across ten states and three administrative areas in South Sudan with a specific focus on reducing maternal and child mortality.
Responding to the needs of Women and Children in Yemen 301140
UK - Foreign, Commonwealth Development Office (FCDO)
This programme will address the devastating impact the conflict in Yemen is having on women and children, particularly the most marginalised. It will provide access to life-saving integrated health, nutrition, water, sanitation and hygiene (WASH) and protection services. This approach responds directly to two key UK humanitarian aims in Yemen: preventing famine and ensuring respect for International Humanitarian Law.
UK-SA Health Systems Strengthening Partnerships Programme
UK - Foreign, Commonwealth Development Office (FCDO)
Support to strengthen South Africa’s health systems to achieve Universal Health Coverage, and drive collaboration on pandemic preparedness
Health Resilience Fund in Zimbabwe 2021-2025
UK - Foreign, Commonwealth Development Office (FCDO)
To support a resilient health system in Zimbabwe that is equipped to deliver quality sexual, reproductive, maternal, newborn, child and adolescent health and nutrition services.
Scaling up Family Planning in Tanzania
UK - Foreign, Commonwealth Development Office (FCDO)
This is a national programme to scale up access to family planning across Tanzania. Specific activities will include: • Outreach work in rural and urban areas as well as in Tanzania’s refugee camps and host communities. • Specific work to improve access to family planning as well as sexual and reproductive health information to youth, people with disabilities as well as services for victims of sexual violence. • Procure family planning commodities, strengthen the supply chain, and train of public health providers
Better Lives for Somali Women and Children
UK - Foreign, Commonwealth Development Office (FCDO)
To achieve UK's manifesto commitment of reducing preventable deaths, the Better Lives for Somali Women and Children will continue to respond to the health and nutrition needs of the Somali people. There will be a continued focus on delivering an essential package of health services. The programme will strengthen the Somali Health Authorities oversight of service provision, which will in turn promote local accountability and allow them increasingly to respond to the needs of their populations. This programme approach aims to support long term sustainability and state building that is part of the wider strategic agenda. There will also be a climate change mitigation component (ICF) within the programme.
Central Asia Small Projects Programme
UK - Foreign, Commonwealth Development Office (FCDO)
This programme will provide the mechanism for embassies to develop small projects to further the aims of the Country Business Plans and develop learning to support wider programming initiatives, with the overall aim of supporting development in the region.
Tackling Deadly Diseases in Africa Programme 2
UK - Foreign, Commonwealth Development Office (FCDO)
The Tackling Deadly Diseases in Africa 2 (TDDAP 2) programme will help implement the UK’s vision for progress on health security in Africa. It will provide technical and financial support to build health security capacity in up to 5 selected countries, including middle ground powers, strengthen key regional bodies such as the Africa Centre for Disease Control and establish long-term partnerships between African, UK and global institutions. Outcomes; • Strengthened regional institutions to help build and improve global health security; • Improved national public health systems and functions with increased national ownership and leadership of outbreak responses; • Communities trained and provided with the knowledge and tools to identify risks and respond to outbreaks; • An emergency response/contingency mechanism to enable the UK to quickly respond to disease outbreaks and help prevent these from escalating to crisis; • Independent monitoring and evaluation component
The Evidence Fund - 300708
UK - Foreign, Commonwealth Development Office (FCDO)
The Evidence Fund procures and manages research and evaluations that primarily benefit ODA eligible countries. Most research and evaluations paid for by the Evidence Fund are country-specific, and all respond to requests for evidence to inform programme or policy decisions. Primarily serving research requests from HMG’s Embassies and High Commissions in ODA eligible countries, and from HMG policy and strategy teams, the Evidence Fund strengthens the evidence behind the UK’s priority international development investments and development diplomacy. The Evidence Fund also invests modest amounts of non-ODA, to strengthen the evidence behind wider UK foreign policy.
Ethiopia Crises 2 Resilience (EC2R)
UK - Foreign, Commonwealth Development Office (FCDO)
The Ethiopia Crises to Resilience (EC2R) programme is aimed to alleviate the impact of the conflict and drought to the poorest Ethiopians. The programme tries to address urgent humanitarian needs while maintaining the delivery of essential services across the country.
International Finance Facility for Immunisation
UK - Foreign, Commonwealth Development Office (FCDO)
Reduce vaccine preventable diseases (VPDs) in poor countries in a sustainable way using innovative financing approach
Tanzania Health Resilience Programme
UK - Foreign, Commonwealth Development Office (FCDO)
Drawing on the UK’s comparative advantage and priorities, and in line with Tanzania’s health sector strategy, the programme will: 1. Increase access, quality and equity of life-saving primary health care services by strengthening health systems that support ending preventable deaths of mothers, new-borns, and children (EPD). 2. Strengthen government ability to respond to health threats by supporting integrated disease surveillance systems at community level, and support preparedness systems and the initial response to disease outbreaks. 3. Support the increase and use of data to inform decision making and resource allocation to deliver equitable health outcomes. The programme will support Tanzania to regain momentum towards achieving Universal Health Coverage (UHC) by 2030 as measured by a change in Tanzania’s UHC index.
Global Antimicrobial Resistance Innovation Fund (GAMRIF) - Global Health Security and Medicines and Healthcare products Regulatory Agency (MHRA)
UK - Department of Health and Social Care (DHSC)
This is an Official Development Assistance (ODA) funded project from the UK Department of Health and Social Care (DHSC)’s Global Antimicrobial Resistance Innovation Fund (GAMRIF) which funds research and development to fight antimicrobial resistance (AMR) in low- and middle-income countries (LMICs) where the burden of drug-resistant infection is greater. This partnership with the Medicines and Healthcare products Regulatory Agency (MHRA) aims to provide regulatory and policy support to GAMRIF funded activities globally by: (1) Providing early-stage regulatory advice through existing innovation accelerator; (2) Underpinning regulatory scientific research to establish the scientific framework for assuring the quality of products; and (3) Providing assistance on the preparation of calibrants and running controls required to measure medicinal products’ critical quality attributes. MHRA will develop non-mandatory regulatory guidance that draws on national guidelines and advice from national regulators, maximising the likelihood that innovative products developed within GAMRIF funded portfolios secure regulatory approval in both LMICs and high-income countries (HICs). This project was not put out to an open, competitive tender process because MHRA is an executive agency of DHSC and therefore exempt from the tender process as it is within DHSC’s body of expertise.
Global Antimicrobial Resistance Innovation Fund (GAMRIF) - Accelerating Antibacterial Innovation with Combating Antibiotic Resistant Bacteria Accelerator (CARB-X)
UK - Department of Health and Social Care (DHSC)
This is an Official Development Assistance (ODA) funded project from the UK Department of Health and Social Care (DHSC)’s Global Antimicrobial Resistance Innovation Fund (GAMRIF) which funds research and development to fight antimicrobial resistance (AMR) in low- and middle-income countries (LMICs) where the burden of drug-resistant infection is greater. This project is delivered in partnership with Boston University’s Combating Antibiotic Resistant Bacteria Accelerator (CARB-X), a non-profit, multi-donor international partnership that supports innovative early product research and development focused on the most dangerous drug-resistant bacteria. This partnership will invest in high-value, innovative research to accelerate the development of products to reduce the harm to human health, welfare and economic growth from drug-resistant infections, up to and including Phase I. The programme will focus on prevention (including vaccines) and alternatives to antibiotics for humans as primarily and directly relevant to people in LMICs.
Global Antimicrobial Resistance Innovation Fund (GAMRIF) - InnoVet AMR: Innovative Veterinary Solutions for Antimicrobial Resistance (AMR) with the International Development Research Centre (IDRC)
UK - Department of Health and Social Care (DHSC)
This is an Official Development Assistance (ODA) funded project from the UK Department of Health and Social Care (DHSC)’s Global Antimicrobial Resistance Innovation Fund (GAMRIF) which funds research and development to fight antimicrobial resistance (AMR) in low- and middle-income countries (LMICs) where the burden of drug-resistant infection is greater. This project is delivered in partnership with the International Development Research Centre (IDRC) and aims to reduce the emerging risk that antimicrobial resistance (AMR) in animals poses to global health and food security. InnoVet-AMR will fund research to develop new animal vaccines and other innovations to fight AMR in livestock (swine and poultry) and aquaculture production, particularly in LMICs. Through InnoVet-AMR, DHSC and IDRC aim to achieve two main objectives: (1) Support research that will identify innovative veterinary solutions, including vaccines and alternative solutions, to reduce the use of antimicrobials in livestock and aquaculture operations in LMICs; and (2) Build effective partnerships to better coordinate discovery, development and sustainable delivery of affordable innovative veterinary solutions to reduce the use of antimicrobials in livestock and aquaculture operations in LMICs. As part of the InnoVet-AMR programme, GAMRIF has also allocated additional funding to a partnership with the International Centre for Antimicrobial Resistance Solutions (ICARS). This complimentary research activity will support scoping and research projects focused on climate change, gender and equity in AMR mitigation.
Global Antimicrobial Resistance Innovation Fund (GAMRIF) - New Antibiotic Treatments with the Global Antibiotic Research and Development Partnership (GARDP) - Phase III
UK - Department of Health and Social Care (DHSC)
This is an Official Development Assistance (ODA) funded project from the UK Department of Health and Social Care (DHSC)’s Global Antimicrobial Resistance Innovation Fund (GAMRIF) which funds research and development to fight antimicrobial resistance (AMR) in low- and middle-income countries (LMICs) where the burden of drug-resistant infection is greater. The project is delivered in partnership with the Global Antibiotic Research and Development Partnership (GARDP), a non-profit product development partnership, hosted by the Drugs for Neglected Diseases Initiative (DNDi) and founded in association with the World Health Organization (WHO). It is a research and development initiative addressing global public health needs by developing, delivering and assuring sustainable access to new or improved antibiotic treatments. GAMRIF funding will support GARDP to develop and deliver new treatments for drug-resistant infections across the following three programmes: (1) Serious bacterial infections (SBIs); (2) Children’s antibiotics (neonatal sepsis and paediatric development); and (3) Sexually transmitted infections (STIs).
UK Public Health Rapid Support Team (UK-PHRST) - Rapid Deployment and Capacity Strengthening
UK - Department of Health and Social Care (DHSC)
This is an Official Development Assistance (ODA) funded project from the UK Department of Health and Social Care (DHSC). The UK Public Health Rapid Support Team (UK-PHRST) is the primary mechanism for the UK Government to deploy technical expertise in outbreak response to ODA-eligible countries, stopping a public health threat from becoming a broader health emergency. It is a partnership between the UK Health Security Agency (UKHSA, formerly Public Health England (PHE)) and the London School of Hygiene and Tropical Medicine (LSHTM) and was established in 2016 in response to lessons learned from the West Africa Ebola outbreak. The UK-PHRST comprises public health experts who work to address the threat posed by infectious disease outbreaks in low- and middle- income countries (LMICs) through an integrated triple remit of: (1) Outbreak Response: Rapidly investigate and respond to disease outbreaks at source in LMICs to stop a public health threat from becoming a broader health emergency by deploying specialist public health experts; (2) Research: Deliver rigorous, collaborative research with partners to improve the evidence base for best practice in epidemic preparedness and response; and (3) Capacity Strengthening: Strengthen leadership, systems and technical capacity for an improved response to disease outbreaks in ODA-eligible countries. This project was not put out to an open, competitive tender process because UKHSA is an executive agency of DHSC with a mandate to deliver on pandemic preparedness and therefore exempt from the tender process as it is within DHSC’s body of expertise.
Advanced filters
To search for Programmes in a specific time period, please enter the start and end dates.